Sanford C. Bernstein
https://www.bernsteinresearch.comSanford C. Bernstein, a division of AllianceBernstein, is a research firm.
View Older Stories View More Recent Stories
-
Bernstein: 'Microsoft (MSFT) and Then Everyone Else'
-
Bernstein on Zoom Video (ZM): 'Expected CY25 Growth Remains Modest'
-
Bernstein on Wayfair (W): 'Returning to Growth, but Spending More Too'
-
Pfizer (PFE) PT Lowered to $30 at Bernstein; 'We Need to See More'
-
Bernstein on Nike (NKE): 'What could the business look like in 2026?'
-
Bernstein on Domino's Pizza (DPZ): 'Share gains and cost discipline is all we can get (for now)'
-
Lam Research (LRCX) PT Raised to $105 at Bernstein SocGen Group
-
Advan Research Corporation Appoints Thomas Paulson as Head of Market Insights
-
RWA Wealth Partners Expands Board of Directors with the Appointment of Doris Meister
-
Lilly offers weight-loss drugs in vials at a discount to fight competition
-
DeepSeek rushes to launch new AI model as China goes all in
-
Here's what analysts are expecting when Agilon reports Q4 earnings: costs, contracts, and cash
-
Bernstein SocGen Group Downgrades Moncler SpA (MONC:IM) (MONRY) to Market Perform
-
Form 4 SYNCHRONOSS TECHNOLOGIES For: Feb 20 Filed by: Bernstein Martin Francis
-
Domino's Pizza (DPZ) PT Raised to $420 at Barclays, 'we struggle with the return to Domino's historical premium valuation'
-
Microsoft data center leases slowing, analysts say, raising investor attention
-
Microsoft has cancelled data center leases in the U.S., TD Cowen says
-
MongoDB (MDB) PT Lowered to $357 at Bernstein; 'FY26 Guidance is an Overhang for the Stock'
-
Bernstein on Snowflake Inc. (SNOW): 'Investors Should Be Comfortable Owning the Stock'; PT Raised
-
Sony Corp. (6758:JP) (SONY) PT Raised to JPY4,600 at Bernstein
-
Bernstein Sees 'Clear Upside' for Eli Lilly's (LLY) Zepbound and Mounjaro Post FDA Announcement
-
Bernstein's Reaction to DOJ Investigation of UnitedHealth Group (UNH)
-
Insulet Corporation (PODD) PT Raised to $335 at Bernstein; 'Strong Q4, Great Setup for 2025'
-
Bernstein on TripAdvisor (TRIP): 'Could 2025 really be the last transition year?'
-
Bernstein Reiterates Market Perform on Booking Holdings (BKNG) After 'A Very Strong Quarter'
-
Is Segro the next big data center stock to watch?
-
Home Depot (HD) vs. Lowe's (LOW): Which stock to own for 2025
-
Bernstein on the endgame of European airline consolidation
-
How would an Intel & TSMC pact impact the supply chain? Bernstein answers
-
What's the current state of China's GLP-1 market?
-
Can the rally in Japanese stocks continue?
-
Form 4 Airbnb, Inc. For: Feb 19 Filed by: Bernstein David C
-
Form 4 Petros Pharmaceuticals, For: Feb 19 Filed by: Bernstein Bruce
-
Cruise: Is a tax tidal wave on the way?
-
KalVista Pharmaceuticals to Present New Sebetralstat Data at the American Academy of Allergy, Asthma & Immunology 2025 Annual Meeting
-
Bernstein Reiterates Outperform on UnitedHealth Group (UNH) Amid Employee Buyout Program
-
Bernstein on Airbus SE (AIR:FP) (EADSY): 'We Still See Airbus as Attractive Long-Term'
-
Bernstein Reiterates Outperform Rating on Walmart (WMT), Recommends 'Buy on Weakness'
-
Ionis Pharmaceuticals (IONS) PT Lowered to $43 at Bernstein SocGen Group
-
Bernstein on Birkenstock Holding plc (BIRK): 'Wholesale Still Best Foot Forward in Calendar 4Q24'
-
Bernstein Explores Dollar Tree (DLTR) Scenarios Amid Potential Family Dollar Sale
-
Bernstein on Quanta Services (PWR): 'The Growth Story Remains Intact'
-
Verona Pharma (VRNA) PT Raised to $80 at Jefferies
-
Guardant Health (GH) PT Raised to $60; Bernstein: 'We Remain Bullish on the Stock'
-
This French stock 'offers a good investment profile': Bernstein
-
Shake Shack (SHAK) PT Lowered to $155 at Barclays
-
Syntiant to Participate at Bernstein’s 3rd Annual TMT Forum
-
Form 4 CARNIVAL PLC For: Feb 18 Filed by: Bernstein David
-
Form 4 CARNIVAL CORP For: Feb 18 Filed by: Bernstein David
-
Rivian is due to report after the bell on Thursday. Here's what to watch out for

